Diagnostics

The creator of virtual visual field testing becomes Carrot, launching a full diagnostics platform to challenge industry giants with a focus on efficiency.

A landmark study reveals a new test can predict and help prevent premature births in low-risk pregnancies, with a Texas hospital playing a leading role.

With a new MD and 270+ stores in five years, Specsavers is intensifying its push to reshape Canada's eyecare landscape. What's next for the disruptor?

In the wake of global infant formula recalls, a new diagnostic tool offers rapid detection of the dangerous cereulide toxin to protect vulnerable patients.

Advocates call for colorectal cancer screening to start at 45 as cases surge in people under 50, raising questions about Canada's readiness.

Microsoft partners with Neuro-AI pioneer HABS to create AI that understands human cognition, ushering in an era of unprecedented innovation and ethical debate.

As evidence for psychedelic therapy mounts, a key advocacy group brings its case to the UN, challenging decades of prohibitive international drug policy.

Eight innovators receive a major prize to pursue high-risk, radical ideas in the fight against Alzheimer’s, aiming to change the paradigm of neuroscience.

By adding powerful new technologies to its genome sequencing, Baylor Genetics aims to solve medical mysteries and end the diagnostic odyssey for patients.

A new partnership between two Chinese biotech leaders aims to create an industrial-scale gene factory, accelerating breakthroughs in medicine and agriculture.

A new Edmonton health centre embeds pharmacy services directly into patient care, aiming to fix a fragmented system and empower local pharmacists.

Vitestro raises $70M from Labcorp and Mayo Clinic to deploy its AI-powered blood-drawing robot, addressing global phlebotomist shortages and care quality.

The new model from Speechmatics masters Arabic-English code-switching, offering unprecedented accuracy for healthcare and enterprise in the MENA region.

National Vision's annual scholarship rewards optometry students exploring AI and telemedicine, revealing a strategic investment in the future of eye care.

Celebrating 80 years, Aveeno renews its foundational ties with Mayo Clinic, launching a new era of oat science research for compromised skin.

Alzheon's pill ALZ-801 shows promise in early AD patients with high genetic risk, offering a potential path that avoids the brain swelling seen in IV drugs.

A new study reveals Canadians lost billions in wages waiting for care. This is the staggering personal and economic cost of the nation's healthcare queues.

The medtech firm will present its wire-free, AI-enhanced capsule endoscopy tech to investors, facing a critical test in a competitive market.

The world's top virologists now have a permanent home at the University of South Florida, forging a new global nexus for pandemic preparedness.

A startup using trained dogs and AI to sniff out cancer from breath samples was just named a "Fierce 15" company. Can this technology change screening?